Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2011; 17(4): 493-498
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.493
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.493
Table 3 Comparative results of other studies analyzing long term outcomes in chronic hepatitis C patients who achieved a sustained virological response n (%)
| Study | IFN-α2b alone or IFN-α2b + RBV | PEG-IFN + RBV | Genotype 1 | Genotype non-1 | No data of genotype |
| George et al[14] | 146 (97) | 4 (3) | 75 (53) | 66 (47) | 9 |
| Veldt et al[15] | 55 (39) | 83 (59) | 56 (39) | 86 (61) | - |
| Chavalitdhamrong et al[16] | 93 (54.4) | 78 (45.6) | 48 (28.1) | 113 (66.1) | 10 |
| Giannini et al[18] | 0 | 231 (100) | 77 (33.3) | 154 (66.7) | - |
| The current study | 0 | 153 (100) | 116 (75.8) | 37 (24.2) | - |
- Citation: Trapero-Marugán M, Mendoza J, Chaparro M, González-Moreno L, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R. Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin. World J Gastroenterol 2011; 17(4): 493-498
- URL: https://www.wjgnet.com/1007-9327/full/v17/i4/493.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i4.493